580 Postmarketing reporting of adverse experiences[ R].The Code of Federal Regulations, FDA, USA, 21CFR600.80Sec.600
6Current Problems in Pharmacovigilance Committee on Safety of Medicines [R], Medicines Control Agency, UK
7Medicine Problem Report [ R], Therapeutic Goods Administration, Australia
880 Postmarketing reporting of adverse drug experiences[R].The Code of Federal Regulations, FDA, USA,21CFR314.80 Sec.314
9305 Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications[R].The Code of Federal Regulations, FDA, USA,21CFR310.305 Sec.310
10Guidance for Industry, Pharmacovigilance of Veterinary Medicinal Products: Management of Periodic Summary Update Reports (PSUs) [R] , VICH GL29, USA
